BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1888167)

  • 1. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast.
    Søreide JA; Lea OA; Kvinnsland S
    Anticancer Res; 1991; 11(3):1323-6. PubMed ID: 1888167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone-binding cyst protein (PBCP) in operable breast cancer: correlations with prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
    Søreide JA; Lea OA; Anda O; Skarstein A; Varhaug JE; Kvinnsland S
    Anticancer Res; 1991; 11(2):601-5. PubMed ID: 2064314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone binding cyst protein in hormone receptor positive breast cancer; a predictive factor for effect of adjuvant tamoxifen treatment.
    Søreide JA; Kolnes J; Skarstein A; Aas T; Kvinnsland S
    Anticancer Res; 1994; 14(5B):2105-8. PubMed ID: 7840507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical correlates of morphologic differentiation in human breast cancer.
    Silva JS; Cox CE; Wells SA; Paull D; Dilley WG; McCarty KS; Fetter BF; Glaubitz LC; McCarty KS
    Surgery; 1982 Sep; 92(3):443-9. PubMed ID: 7202259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone-binding cyst protein in human breast tumor cytosol.
    Lea OA; Kvinnsland S; Thorsen T
    Cancer Res; 1987 Dec; 47(23):6189-92. PubMed ID: 3677070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved measurement of androgen receptors in human breast cancer.
    Lea OA; Kvinnsland S; Thorsen T
    Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters.
    Dittadi R; Donisi PM; Brazzale A; Marconato R; Spina M; Gion M
    Anticancer Res; 1992; 12(6B):2005-10. PubMed ID: 1363513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tamoxifen on the tumor content of steroid hormone receptors (ER, PgR and AR) in patients with primary breast cancer.
    Lundgren S; Søreide JA; Lea OA
    Anticancer Res; 1994; 14(3B):1313-6. PubMed ID: 8067700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-steroid receptors in human breast cancer. Incidence and interrelationships.
    Valyani SH; Roberts JV; Colletta AA; Iqbal MJ
    Anticancer Res; 1987; 7(6):1281-3. PubMed ID: 3442418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.
    Pekonen F; Partanen S; Mäkinen T; Rutanen EM
    Cancer Res; 1988 Mar; 48(5):1343-7. PubMed ID: 2963690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors.
    Isola JJ
    J Pathol; 1993 May; 170(1):31-5. PubMed ID: 8100853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].
    Reiner G; Jakesz R; Kolb R; Kühnl-Brady K; Reiner A; Schemper M; Spona J
    Dtsch Med Wochenschr; 1988 Jun; 113(22):892-7. PubMed ID: 3371221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progesterone receptors in the normal female breast.
    Ricketts D; Turnbull L; Ryall G; Bakhshi R; Rawson NS; Gazet JC; Nolan C; Coombes RC
    Cancer Res; 1991 Apr; 51(7):1817-22. PubMed ID: 2004366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?
    Søreide JA; Lea OA; Kvinnsland S
    Breast Cancer Res Treat; 1987; 9(2):123-8. PubMed ID: 3620714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
    Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
    Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary origin of metastases. Immunohistochemical determination.
    Chaubert P; Hurlimann J
    Arch Pathol Lab Med; 1992 Nov; 116(11):1181-8. PubMed ID: 1444749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
    van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC
    Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.